Takeda Pharmaceutical Company Limited
Aromatic ring compound
Last updated:
Abstract:
Provided is a compound having a cholinergic muscarine M1 receptor positive allosteric modulator activity. A compound represented by the formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a cholinergic muscarine M1 receptor positive allosteric modulator activity, and is useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like.
Status:
Grant
Type:
Utility
Filling date:
9 Mar 2017
Issue date:
4 Feb 2020